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Case report 
Case series of trans-thoracic nodule aspirate performed by 
interventional pulmonologists 
Daniel Knox, MD a,b,*, Kyle Halligan, MD b 
a Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT, USA 
b Division of Pulmonary, Allergy & Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA, USA   
A R T I C L E  I N F O   
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A B S T R A C T   
Percutaneous interventional tissue sampling of pulmonary masses and lymphadenopathy is a means for diagnosis 
of thoracic malignancy. The user base that can perform this skill with ultrasound guidance is expanding. A 
retrospective cohort of fine needle aspiration and percutaneous core biopsies was identified to evaluate their 
safety and efficacy. 47 distinct procedures were performed by a university medical center’s Interventional 
Pulmonary service between 2012 and 2018.39 consecutive procedures were diagnostically successful by 
percutaneous means, with 34 of the successful diagnoses based on fine needle aspiration alone. In our cohort by 
percutaneous biopsy the most common diagnosis was Non-Small Cell Lung Cancer with 28 samples, followed by 
Small Cell Lung Cancer with 7 samples as well as additional solitary diagnoses of suspected infection, Hepato-
cellular Cancer, Hodgkin Lymphoma and Malignant Melanoma. 4 procedures had complications, two of which 
resolved post procedure with observation and two pneumothoracies which resolved with chest tube placement 
and hospital observation. A wide variety of diagnoses were obtained with percutaneous biopsies with 83% of 
percutaneous biopsies performed by Interventional Pulmonologists achieving diagnostic success.   
1. Introduction 
Ultrasound guided biopsies have been published in the radiology and 
pathology fields dating back to 1976 [1]. The more recent adoption of 
chest ultrasound in pulmonary and critical care medicine has increased 
the skill with which providers can perform dynamically led procedures. 
We planned to assess the safety and efficacy of interventional pulmo-
nologists performing ultrasound guided lymph node and chest biopsies 
in a retrospective cohort. 
2. Methods 
At a quaternary care university medical center, a retrospective 
cohort of consecutive procedures performed by the Interventional Pul-
monary service between 2012 and 2018 was reviewed. Cases were 
defined by Current Procedural Terminology (CPT) codes 10022 (FNA 
with imaging), 32405 (percutaneous core biopsy), 76942 (ultrasound 
guidance for biopsy). This study was approved by the UMASS Medical 
School Institutional Review board, #H00015504. 
All patients who had pulmonary masses that were abutting the 
pleura or who had enlarged head/neck lymph nodes who were seen by 
the Interventional Pulmonary service underwent biopsy by the Inter-
ventional Pulmonary service. 
The consented sterile procedures were performed under local anes-
thetic using a SonoSite® (Bothell, WA) ultrasound with both linear and 
curvilinear probes. An eight-centimeter 22 gauge fine needle aspiration 
(FNA) or less commonly an eight-centimeter 18 gauge Temno core bi-
opsy were used for sample collection. Passes were given to onsite pa-
thology who determined adequacy of the sample and transferred 
biopsies to the department of pathology. 
Post procedure, patients were evaluated by either three-point ultra-
sound to establish lung sliding or chest radiograph. Charts were manu-
ally reviewed by one reviewer and complications and diagnoses 
confirmed. Final diagnosis was established from all future biopsy or 
surgical resection if performed. 
Data was analyzed in R and Fischer Exact Tests were used to compare 
groups. P < 0.05 was considered significant. 
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3. Results 
47 distinct procedures were identified. 36 (75%) of the patients were 
smokers Table 1. 83% (39) of procedures were diagnostically successful, 
Table 2. 72% (34) of procedures had a diagnosis via fine needle aspi-
ration alone. 30% (14) of the procedures were ultrasound guided head/ 
neck lymph node biopsies. Of the 8 non-diagnostic percutaneous bi-
opsies, future pathological samples revealed 4 were non-small cell lung 
cancer, 1 was a T cell lymphoma and 2 resolved with antibiotics and 
time. 1 sample remained undiagnosed. Table 2. 
There was no statistical difference on size of biopsy and rate of 
diagnostic yield or procedure complications. Table 3. 
Of the 33 transthoracic biopsies, 12% (4) of procedures had com-
plications and 12% (4) were nondiagnostic. Two pneumothoracies, 
which both resolved with chest tube placement for three days in the 
hospital. One episode of hemoptysis which resolved within several hours 
without intervention and observation alone. And one vasovagal episode 
which was fully resolved with post procedural monitoring. 
There was a mean of 5 passes on all the biopsy sites. Mean size of 
transthoracic target was 5.6 cm in the smaller dimension. All of them 
were adjacent to the pleura by ultrasound. Table 4. 
4. Conclusions 
In this cohort, ultrasound guided transthoracic FNA and core bi-
opsies were well tolerated with complications in line with recent re-
ported literature and less than prior CT guided techniques [2]. 
Furthermore, FNA alone was often diagnostic. Interventional Pulmo-
nologists appear to be able perform ultrasound guided biopsies both 
effectively and safely. 
Table 1 
Demographics mean (IQR) or % (n).  
Female 60% (28) 
Age 68 (60,77) 
BMI 26 (22,30) 
Height (cm) 165 (157,171) 
Weight (kg) 70.3 (57.9,81.5) 
Tobacco Use 
Never 6% (3) 
Active 17% (12) 
Quit 51% (24) 
No Data 17% (8)  
Table 2 
Biopsy pathology vs. Final Pathology for all biopsy sites.   



























Infection Likely 0 0 0 0 0 0 0 0 0 1 
Hepatocellular CA 1 0 0 0 0 0 0 0 0 0 
Hodgkin 
lymphoma 
0 1 0 0 0 0 0 0 0 0 
Malignant 
melanoma 
0 0 1 0 0 0 0 0 0 0 




0 0 0 0 8 1 0 0 0 0 
NSCLC: 
Adenocarcinoma 
0 0 0 0 0 11 0 0 0 0 
NSCLC: Squamous 0 0 0 0 0 0 8 0 0 0 
Small Cell Lung 
Cancer 
0 0 0 0 0 0 0 7 0 0  
Table 3 
Final Pathology by size of tumor (in cm) for chest biopsies.   
2 ≤ T <
4 
4 ≤ T <
6 
6 ≤ T <
8 




Infection Likely 1 0 0 0 0 
Hepatocellular CA 0 1 0 0 0 
Hodgkin lymphoma 0 0 1 0 0 
Malignant melanoma 1 0 0 0 0 
Non-diagnostic 2 1 3 0 0 
NSCLC 1 2 1 0 1 
NSCLC: 
adenocarcinoma 
2 1 1 1 2 
NSCLC: squamous 0 5 2 0 1 
Small cell 1 0 1 0 1  
Table 4 
Biopsy site data. N or mean (IQR).   
Transthoracic biopsies Lymph node biopsies 
Number of procedures 33 14 
Number of passes 5 (3–7) 5 (4–5) 
Smaller Dimension (cm) 5.6 (4–7) 2 (2–2) 
Larger Dimension (cm) 7.6 (5–11) 2 (2–2)  
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